Activation of extracellular signal-regulated kinase (Erk) 1͞2, which plays a critical role in diverse cellular processes, including cell proliferation, is known to be mediated by the canonical Rafmitogen-activated protein kinase kinase (MEK) kinase cascade. Alternative MEK-independent signaling pathways for Erk1͞2 activation in mammalian cells are not known. During our studies of human primary Schwann cell response to long-term infection of Mycobacterium leprae, the causative organism of leprosy, we identified that intracellular M. leprae activated Erk1͞2 directly by lymphoid cell kinase (p56Lck), a Src family member, by means of a PKC-dependent and MEK-independent signaling pathway. Activation of this signaling induced nuclear accumulation of cyclin D1, G 1͞S-phase progression, and continuous proliferation, but without transformation. Thus, our data reveal a previously unknown signaling mechanism of glial cell proliferation, which might play a role in dedifferentiation as well as nerve regeneration and degeneration. Our findings may also provide a potential mechanism by which an obligate intracellular bacterial pathogen like M. leprae subverts nervous system signaling to propagate its cellular niche for colonization and long-term bacterial survival.
S
chwann cell proliferation is crucial for the development of the peripheral nervous system, nerve regeneration and degeneration, and tumorigenesis (1-3). However, much less is known about the signaling mechanisms that regulate Schwann cell proliferation. Among the cell signaling cascades, activation of extracellular signalregulated kinase (Erk) 1 and Erk2 signaling play a critical role in cell proliferation (4, 5) . The activation of Erk1͞2 in response to extracellular cues, such as growth factors, requires phosphorylation by mitogen-activated protein kinase kinase (MEK) 1͞2 by means of Raf family kinases, and MEK1͞2 are the only known activators of Erk1͞2 (4) (5) (6) . No alternative MEK1͞2-independent signaling pathways that activate Erk1͞2 in mammalian cells have been described.
We have shown that myelinating and nonmyelinating Schwann cells display distinct functional responses to infection with Mycobacterium leprae, the causative organism of leprosy, and cell proliferation is a common feature during infection (7) (8) (9) . Subsequent to infection, M. leprae preferentially invade human nonmyelinating Schwann cells and maintain long-term intracellular bacterial survival, which eventually leads to irreversible immune-mediated peripheral nerve damage, the hallmark of leprosy (10) (11) (12) (13) (14) . One key to the pathogenic potential of M. leprae survival lies in the ability of this extremely slow-growing and strictly obligate intracellular bacterium to propagate its preferred niche so that sufficient Schwann cells are available for bacterial residence, survival, and replication (7, 8, 13) . Using highly purified primary human Schwann cells, which mimic nonmyelinating phenotype-like Schwann cells, we found that M. leprae have the capacity to induce Schwann cell proliferation from inside the cells several weeks after infection. Because mammalian cell proliferation is defined as the increase in cell number resulting from completion of the cell division cycle in response to extracellular signals (15) , we investigated the signaling mechanisms by which intracellular M. leprae regulate human Schwann cell cycle and proliferation.
Materials and Methods

Isolation, Purification, and Characterization of Human Primary
Schwann Cells. Human Schwann cells were isolated from peripheral nerve tissues (provided by Patrick Wood, University of Miami, through the Organ Procurement Organization, Miami), which consisted of nerve roots making up the cauda equina (16) . (See Supporting Materials and Methods, which is published as supporting information on the PNAS web site, for detailed procedures.)
Infection of human Schwann cells with in vivo grown M. leprae was carried out as described in refs. 7 and 9. M. leprae used in this study were derived from the footpads of athymic nu͞nu mice (17) and were provided by J. L. Krahenbuhl (National Hansen's Disease Programs Laboratory, Baton Rouge, LA).
Gene Array and Real-Time Quantitative RT-PCR (TaqMan) Analyses.
Human genome Affymetrix (Santa Clara, CA) GeneChips were used to determine differential cell cycle gene expression in human primary Schwann cells in response to intracellular M. leprae. For real-time RT-PCR, primers and fluorescently labeled probes from the coding regions of human cell cycle regulators were designed by using VECTOR NTI software (Invitrogen). Experimental details of gene array and real-time PCR are described in Supporting Materials and Methods.
RT-PCR, electron microscopy, antibodies, immunofluorescence, Western blot analysis, proliferation assays (BrdUrd uptake), pharmacological inhibition of kinases, kinase activity assays, cell cycle FACS analysis, transformation assays, and transfection experiments are all detailed in Supporting Materials and Methods.
Results and Discussion
Schwann cells serve as a reservoir for M. leprae after peripheral nervous system infection (7, 8, 10, 11) . To recapitulate the fate of human Schwann cells in response to long-term intracellular residence of M. leprae in vivo, we isolated adult Schwann cells from peripheral nerves from different human donors, and each isolate was purified to homogeneity by FACS sorting using mAbs against neurotrophin receptor p75 as a marker for Schwann cells (18) , and further characterized (Fig. 6 , which is published as supporting information on the PNAS web site). These Schwann cells efficiently engulfed M. leprae ( Fig. 1 A-C) and are functionally similar to nonmyelinating-like phenotypes (7).
We maintained infected primary cultures up to 15 and 30 days (in some cases up to 40 days) and demonstrated bacterial presence exclusively inside Schwann cells ( Fig. 1 A-C and E) . Strikingly, human Schwann cells that harbor intracellular M. leprae showed increased cell proliferation. Infected cells with numerous M. leprae showed a significant increase in uptake of BrdUrd (5-bromodeoxyuridine), which represents S-phase cells (Fig. 1D) , and in the division of cell nuclei, which represents mitosis ( Fig. 1E and Insets). The infected cells exhibited no signs of apoptosis or cytopathic effects (Fig. 7 , which is published as supporting information on the PNAS web site). Cell cycle FACS analysis revealed that the total cell count in G 1 phase of 30-day-infected Schwann cells was significantly reduced compared with controls, whereas infected cells, particularly in G 2 phase, were dramatically increased (Fig. 1F) . This finding suggests that intracellular M. leprae accelerated G 1 phase progression with earlier S-phase entry and that significant numbers of cells have entered G 2 phase. In agreement with these results, we found a significant increase of the total number of infected cells 15 and 30 days after infection (P Ͻ 0.0001), and Ϸ60% of Schwann cells at 30 days still harbored considerable numbers of M. leprae (Fig. 1C) . Thus, we concluded that cell cycle progression and proliferation are due to Schwann cell response to long-term residence of intracellular M. leprae.
To begin to address how intracellular M. leprae modulate the human Schwann cell cycle, we used Affymetrix human GeneChips to identify key cell cycle genes. Among the differentially expressed cell cycle genes, and on the basis of relative gene expression by Ͼ2-fold criteria (Affymetrix DATA MINING TOOL 3.0 software), it was found that cyclin D1 and p21, two of the key G 1 phase cell cycle regulators (19) , were significantly up-regulated at day 30 but not at day 3 or 7 ( Fig. 2A) . Because three separate gene array experiments with 30-day-infected Schwann cells from two different organ donors confirmed these findings (Fig. 2B) , we focused most of our subsequent studies on day 30 postinfection. We further validated gene array data by performing real-time quantitative RT-PCR (TaqMan, Applied Biosystems) using specific primer͞probe combinations for human cyclin D1 and p21 (Fig. 2C) . Together, these results suggest that intracellular M. leprae, after long incubation (30 days), induce cyclin D1 and p21 gene transcription in human Schwann cells.
Consistent with gene expression data, total cyclin D1 protein was significantly up-regulated in 30-day-infected cells in asynchronized cultures (Fig. 2D ). However, there was no change in expression of p21 protein despite the up-regulation of p21 gene at day 30. The reason for the lack of increase in p21 protein with up-regulated p21 mRNA transcript is currently unclear. Hence, we focused our studies on cyclin D1 and examined the role of Erk1͞2 signaling in M. leprae regulation of cyclin D1 on the basis of increased Erk1͞2 phosphorylation in 30-day-infected cells ( Fig. 2D) .
Modulating the abundance of cyclin D1 is one means by which cells control their progression through G 1 phase of the cell cycle and subsequent proliferation (15, 19, 20) . To test the direct role of cyclin D1 in M. leprae-induced cell cycle progression, 30-day-infected and control primary human Schwann cells were transiently transfected with a dominant-negative mutant (DNM) of cyclin D1 (T156A with N-terminal FLAG; Fig. 8 , which is published as supporting information on the PNAS web site). T156A expression is known to prevent nuclear accumulation of cyclin D1 and induce cell cycle arrest by blocking G 1 phase progression (21) . The overexpression of the cyclin D1 DNM in 30-day-infected Schwann cells reversed the effects of intracellular M. leprae on Schwann cell cycle progression (Fig. 2E) . G 1 population was significantly increased with a concomitant decrease in S and G 2 populations in 30-day-infected͞ T156A transfected cells, suggesting that functional blockade of cyclin D1 is sufficient to abolish G 1 ͞S-phase progression in Schwann cells induced by intracellular M. leprae.
The regulation of cyclin D1 and subsequent G 1 phase progression require the participation of multiple signaling pathways, which include Erk1͞2 and phosphatidylinositol 3-kinase (PI3K) signaling that are normally activated by binding of growth factors and extracellular matrix proteins to receptor tyrosine kinase and integrins, respectively (19, 22, 23) . Because the observed cyclin D1 up-regulation in infected Schwann cells is a consequence of cellular response to intracellular M. leprae (Fig. 1C) , we examined whether Erk1͞2 signaling can be activated by M. leprae from inside the cells as an intracellular cue. Even after complete removal of serum and heregulin-1␤, a potent Schwann cell mitogen that activates Erk1͞2 by means of the Ras͞Raf͞MEK pathway in primary cultures (24) , infected cells showed a significant phosphorylation of Erk1͞2 compared with controls (Fig. 3A) .
If intracellular M. leprae use canonical growth factor-activated SOS͞Ras͞Raf͞MEK (or PI3K͞Akt) pathways to phosphorylate Erk1͞2 (for example, by inducing the release of Schwann cell growth factors by an autocrine pathway), specific inhibition of SOS and MEK (or PI3K) should block downstream phosphorylation of Erk1͞2 (22) (23) (24) (25) . We have used well characterized pharmacological inhibitors U0126 and LY294002, which are specific for MEK1͞2 and PI3K, respectively [MEK inhibitor (MEKI) and PI3K inhibitor (PI3KI), respectively] (22-24). Despite serum starvation and continuous presence of U0126 and LY294002 for 48 h, phosphorylation of Erk1͞2 was not inhibited in infected Schwann cells (Fig. 3B) . Similar pErk1͞2 activation was detected with U0126 alone (data not shown). As expected, phosphorylation of MEK1͞2 was inhibited in both controls and infected cells (Fig. 3B) . In addition, treatment of synchronized infected Schwann cells with SOSinhibitory peptide, which abolishes the upstream Ras-dependent Erk1͞2 signaling (25) , also failed to inhibit the phosphorylation of Erk1͞2 in infected Schwann cells (Fig. 3B) . In contrast, heregulin-1␤-induced activation of Erk1͞2, which is mediated by the Ras, Raf, and MEK1͞2 pathways in Schwann cells (24) , is markedly inhibited by U0126 and SOS inhibitors (data not shown). We then examined the capacity of activated cellular Erk1͞2 to phosphorylate its downstream target transcription factor, Elk-1. Active Erk1͞2 immunoprecipitated from infected synchronized Schwann cells in the presence of inhibitors produced significantly higher phosphorylation of Elk-1 compared with noninfected Schwann cells (Fig. 3C) , further suggesting the ability of M. leprae to induce Erk1͞2 kinase activity independent of the MEK1͞2 pathway.
We next examined the role of M. leprae-induced Erk1͞2 signaling in G 1 ͞S-phase regulation by transiently transfecting cells with a p44 mapk DNM T192A (23) . Infected Schwann cells transfected with T192A showed a significant reduction in total cyclin D1 protein expression and in S-phase population compared with cells transfected with an empty vector (P Ͻ 0.001) (Fig. 3D) , suggesting the direct involvement of M. leprae-induced Erk2 in cyclin D1 expression and S-phase entry of infected cells. To elucidate the signaling mechanisms by which intracellular M. leprae induce MEK-independent Erk1͞2 activation, 30-dayinfected Schwann cells were serum-starved for 48 h with known inhibitors of major signaling pathways. We found that PKC paninhibitor (PKCI) bisindolyl maleimide-I (20 nM) (26) , in the presence of MEKI and PI3KI, significantly blocked M. lepraeinduced phosphorylation of Erk1͞2 (Fig. 4A) , suggesting a critical role of PKC in MEK-independent activation of Erk1͞2.
The PKC family comprises Ϸ12 different isoforms that are phospholipid-dependent serine͞threonine kinases and are broadly classified by their activation characteristics (27) . To identify the PKC isoform(s) responsible for M. leprae-induced Erk1͞2 activation, we used previously characterized DNMs of PKC isoforms (28) . Infected cells transfected with DNM-PKC, but not with other DNMs of PKC isoforms, significantly down-regulated Erk1͞2 phosphorylation (Fig. 4B) . This result was further confirmed by phospho-specific antibody to PKC, which showed a strong activity in synchronized infected cells, compared with weak or no reaction in controls (Fig. 4C) . Specificity of the former was confirmed by PKCI, which completely abolished PKC phosphorylation (Fig.  4C) . We also tested the activities of other phospho-specific antibodies to PKC␣͞␤II, PKCѨ, PKD͞PKC, PKD͞PKC, PKC, and PKC͞, but none except PKC␣͞␤II showed reactivity in human Schwann cells (data not shown). Because DNMs of PKC␣ and PKC␤II had no effect on Erk1͞2 (Fig. 4B) , we concluded that PKC is involved in M. leprae-induced Erk1͞2 activation. Although PKC isoforms including PKC have been shown to activate Erk1͞2 by means of c-Raf and MEK (27) (28) (29) , it is unknown whether PKC isoforms can activate Erk1͞2 by MEK-independent pathways. Because Erk1͞2 is not a substrate for PKC (29) , it is likely that MEK-independent Erk1͞2 phosphorylation in infected Schwann cells is mediated by another signaling kinase(s) that serve as PKC-activated intermediate(s).
One of the kinase substrates of PKC is lymphoid cell kinase (Lck) p56Lck, a member of nonreceptor Src family tyrosine kinases, which was originally thought to express preferentially in lymphoid tissues (30) . Lck is of special interest, because the recombinant form of murine Lck has been shown to phosphorylate Erk1͞2 in vitro (31) . Because Lck is a substrate for PKC (32) and PKC is involved in M. leprae-induced Erk1͞2 phosphorylation (Fig. 4 A-C) , we examined whether a pharmacological inhibitor of Src kinases, PP2, that blocks Lck (LckI) (33) could inhibit M. leprae-induced Erk1͞2. When 30-day-infected cells were incubated with LckI (10 M) in the presence of MEKI and PI3KI for 48 h, a significant reduction of M. leprae-induced phosphorylation of Erk1͞2 was observed (Fig.  4D) , suggesting a potential role of Lck in MEK-(and PI3K-) independent activation of Erk1͞2 in human Schwann cells.
Because the expression and function of Lck in the peripheral nervous system is unknown, we first determined the expression of Lck in primary human Schwann cells and sciatic nerves. Whereas Lck gene expression in control and infected Schwann cells showed no difference in RT-PCR (Fig. 4E ), a major difference was found in migration pattern of total Lck protein (nonphosphorylated) in SDS͞PAGE (Fig. 4F) . In synchronized control human Schwann cells, total Lck appeared as a slow-migrating Ϸ65-kDa band. However, in infected cells, Lck showed a prominent lower band at Ϸ60 kDa and a weaker 56-kDa band (Fig. 4F Left) . Both 60-kDa and Ϸ65-kDa Lck proteins were detected in human sciatic nerve (Fig. 4F Right) , suggesting that Lck in peripheral nerves exists in two configurations. Indeed, the configurational changes in Lck proteins in inactive (Ϸ65-kDa) and active (Ϸ60-kDa) stages of T cells have been shown and are known to occur by intramolecular interactions as well as phosphorylation and dephosphorylation (34, 35) . In Schwann cells, the observed migration difference in total Lck is likely due to similar configurational changes caused by M. lepraeinduced cell activation.
Lck is regulated by phosphorylation on multiple residues, including Ser-158 in the SH2 domain (36) . In T cell lines, specific PKC-mediated phosphorylation has been shown at Ser-158 of the active form of the Lck molecule (37) . We tested whether Lck is phosphorylated at Ser-158. By using phospho-specific antibody to Lck͞Ser-158, we detected phosphorylation only in the lysates of M. leprae-infected Schwann cells (Fig. 4G) . Consistent with the total Lck protein expression pattern, phospho-Lck-Ser-158 was associated only with the 60-kDa band in infected cells (Fig. 4G) . Both LckI and DNM-PKC abolished phosphorylation of Lck-Ser-158, suggesting the role of PKC in M. leprae-induced Lck activation (Fig. 4G) . In contrast, unlike intracellular M. leprae, heregulin-␤1, which activates Erk1͞2 by means of the Ras͞Raf͞MEK pathway (24) , failed to phosphorylate Lck-Ser-158 in Schwann cells (Fig. 9 , which is published as supporting information on the PNAS web site).
To assess the role of Schwann cell Lck͞Ser-158 in direct phosphorylation of Erk1͞2, we performed an in vitro kinase assay with antibody to phospho-Lck͞Ser-158. Phospho-Lck͞Ser-158 immunoprecipitates from M. leprae-infected Schwann cells, but not from controls, directly phosphorylated Erk2 in vitro (Fig. 4H) . These results were consistent with Schwann cells isolated from two different human donors (data not shown). In addition, we performed in vitro phosphorylation kinase assay using anti-phosphoTyr antibody. Because Erk2 can be autophosphorylated on tyrosine residues in the presence of ATP (31), recombinant Erk2 was used as a positive control. Phospho-Lck͞Ser-158 immunoprecipitated from the lysates of infected Schwann cells showed 2-fold increase in phosphorylation of Erk2 on tyrosine residues compared with autophosphorylated Erk2 (Fig. 4H) . These data together suggest that phosphorylated Lck-Ser-158 in human Schwann cells serves as a direct activator of Erk1͞2 independent of MEK1͞2.
Although MEKIs and PI3KIs are known to block growth factorinduced Erk1͞2 activation, nuclear cyclin D1, and cell cycle pro- gression (22, 24) , these inhibitors did not affect M. leprae-induced Erk1͞2 phosphorylation, nuclear cyclin D1, and the net S-phase cell population ( Fig. 5 A and B) . However, addition of LckI and PKCI to the above combination of inhibitors dramatically reduced the nuclear cyclin D1 and the net S-phase cell population (Fig. 5 A and  B) . Similar reduction was also observed when infected cells were incubated with LckI alone (Fig. 5B) . In contrast, Lck inhibitor did not affect the net S-phase Schwann cell population induced by heregulin-␤1 (Fig. 9B) , which is consistent with the failure to induce phosphorylated Lck-Ser-158 by heregulin-␤1 (Fig. 9A) . These results show that a MEK-independent and Lck-dependent Erk1͞2 signaling induced by intracellular M. leprae promotes G 1 ͞S-phase transition of human Schwann cells, and this signaling pathway does not appear to operate in heregulin or extracellular mitogen-induced cell cycle progression (Fig. 5C ).
Unlike Erk1͞2 activation by the canonical Ras͞Raf͞MEK pathway, whose sustained activation leads to cell transformation (22) , sustained activation of Lck-dependent Erk1͞2 does not appear to cause cell transformation (Fig. 10 , which is published as supporting information on the PNAS web site). Therefore, it is possible that intracellular M. leprae, by activating Lck-dependent Erk1͞2, reduce the risk of tumorigenesis so that highly controlled cell propagation can be maintained during long-term infection. Considering the strict obligate intracellular parasitic nature of M. leprae, it is likely that this bacterium has evolved to subvert vital putative Schwann cell signaling pathways such as MEK-independent and Lckdependent activation of Erk1͞2 from inside the cell as an effective bacterial strategy for cell proliferation (Fig. 5C ). This study, using M. leprae as an intracellular cue, also reveals a signaling mechanism for cell proliferation. The control of nuclear accumulation of cyclin D1 and G 1 ͞S-phase progression by the activation of Erk1͞2 by means of a MEK-independent and Lck-dependent signaling pathway was previously unknown and reflects a regulatory mechanism of glial cell proliferation that might play a role in dedifferentiation as well as nerve degeneration and regeneration. 
